Please login to the form below

Not currently logged in
Email:
Password:

Tiziana Life Sciences

This page shows the latest Tiziana Life Sciences news and features for those working in and with pharma, biotech and healthcare.

Shire strikes bi-specific antibody deal with Novimmune

Shire strikes bi-specific antibody deal with Novimmune

A.”. The financials of the deal were not disclosed, but the partnership brings about good news for Novimmune, who also has deals in place with Tiziana Life Sciences and Roche.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Taking a lean and careful approach Taking a lean and careful approach

    Kunwar Shailubhai on why biotech is a roller coaster and how Tiziana Life Sciences is pursuing its mission to tackle unmet needs. ... At 58 years old, he is still shuttling between the US and the UK as the London-based company, Tiziana Life Sciences,

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences

    London, UK-based biotechnology group Tiziana Life Sciences has appointed its non-executive director Dr Kunwar Shailubhai as chief executive officer and chief scientific officer. ... He said: “This is a crucial time to be taking on this new role with

  • Tiziana Life Sciences appoints clinical sciences VP Tiziana Life Sciences appoints clinical sciences VP

    Dr Robert Evans joins the UK biotechnology firm. London-based Tiziana Life Sciences has appointed Dr Robert Evans as its new vice president of clinical sciences. ... James Tripp, chief operating officer at Tiziana Life Sciences, said: “Bob's extensive

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics